南美洲和中美洲肺癌筛查市场预测至 2030 年 - 区域分析 - 按癌症类型 [非小细胞肺癌 (NSCLC) 和小细胞肺癌]、技术 [低剂量计算机断层扫描 (LDCT)、胸部X 射线、液体活检等]、年龄组（50 岁及以上和 50 岁以下）和最终用户（医院、诊断中心等）
No. of Pages: 100 | Report Code: BMIRE00029065 | Category: Life Sciences
No. of Pages: 100 | Report Code: BMIRE00029065 | Category: Life Sciences
随着该地区医疗保健意识的不断增强，该地区的肺癌筛查提供商拥有充足的机会。其中包括与地区医院和诊所合作，通过这些医院和诊所可以提供方便的肺癌筛查，并利用偏远地区的远程医疗。这种方法不仅可以早期发现肺癌，还可以改善患者的治疗结果，填补该地区医疗保健的关键空白。通过满足预防性护理不断增长的需求，这些提供者可以在前景广阔的市场中站稳脚跟，最终为改善整个地区的公共卫生和福祉做出贡献。
南部和中部地区中美洲肺癌筛查市场分为巴西、阿根廷和南美其他地区。中美洲。该地区的增长归因于多种因素，例如肺癌发病率的增加和人们对肺癌筛查意识的增强。此外，政府对筛查的支持不断增加，导致市场进一步增长。
肺癌筛查市场正受到癌症患病率上升等因素的影响。例如，根据 Globocan 2020 报告，肺癌是巴西第二大流行癌症。巴西发现了 88492 例新肺癌病例。
肺癌筛查被认为是全球的护理标准。在巴西，其实施过程中的复杂因素与卫生系统的组织、CT 扫描和治疗方法的获取以及对该方法的文化接受程度有关，限制了这一进程。根据当地组织的说法，进行筛查存在挑战和障碍；然而，在所有情况下都有可能获得令人满意的结果。
根据肺癌政策网络，在巴西，有必要采取协调一致的肺癌筛查方法，因为卫生援助全国各地的情况分散，导致严重的健康不平等。最近，第二次巴西早期肺癌筛查试验 (BRELT2) 描述了 LDCT 筛查的优势。尽管如此，在全国范围内实施有组织的筛查计划之前，仍有许多障碍需要克服，包括公共和私人医疗保健机构之间使用筛查设备的不平等。为了应对这一挑战，作为 Propulmó 移动项目的一部分，巴雷托斯（圣保罗）市卫生办公室与当地癌症医院合作，在社区提供移动 LDCT 筛查和戒烟干预措施。
< p>
南部和中部地区中美洲肺癌筛查市场按癌症类型、技术、年龄组、最终用户和国家/地区进行细分。
基于癌症类型、南部和南部地区;中美洲肺癌筛查市场分为非小细胞肺癌（NSCLC）和小细胞肺癌。非小细胞肺癌 (NSCLC) 细分市场在南美和北美地区占有较大份额。 2022年中美洲肺癌筛查市场。
以技术为基础，南美洲和美国中美洲肺癌筛查市场分为胸部 X 射线、低剂量计算机断层扫描 (LDCT)、液体活检等。胸部 X 光检查部分在南、北地区占据最大份额。 2022 年中美洲肺癌筛查市场。
根据年龄组，南部和南部地区肺癌筛查市场中美洲肺癌筛查市场分为 50 岁及以上，50 岁以下。50 岁及以上细分市场在南美和北美地区占据较大份额。 2022 年中美洲肺癌筛查市场。
根据最终用户，南美洲和南美洲的肺癌筛查市场。中美洲肺癌筛查市场分为医院、诊断中心等。医院部门在南部和南部地区占据最大份额。 2022 年中美洲肺癌筛查市场。
按国家/地区划分，南部和非洲地区中美洲肺癌筛查市场分为巴西、阿根廷和南美洲其他地区。中美洲。巴西在南部和南部地区占据主导地位。 2022 年中美洲肺癌筛查市场。
Siemens AG、Koninklijke Philips NV、Canon Inc、Medtronic 和 GE HealthCare Technologies Inc 等在南部和南部地区运营的领先公司中美洲肺癌筛查市场。
Strategic insights for South & Central America Lung Cancer Screening involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 39.16 Million |
| Market Size by 2030 | US$ 68.95 Million |
| Global CAGR (2022 - 2030) | 7.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 癌症类型
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South & Central America Lung Cancer Screening refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Lung Cancer Screening Market is valued at US$ 39.16 Million in 2022, it is projected to reach US$ 68.95 Million by 2030.
As per our report South & Central America Lung Cancer Screening Market, the market size is valued at US$ 39.16 Million in 2022, projecting it to reach US$ 68.95 Million by 2030. This translates to a CAGR of approximately 7.3% during the forecast period.
The South & Central America Lung Cancer Screening Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Lung Cancer Screening Market report:
The South & Central America Lung Cancer Screening Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Lung Cancer Screening Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Lung Cancer Screening Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Lung Cancer Screening Market
